Cost utility of competing strategies to prevent endoscopic transmission of carbapenem-resistant enterobacteriaceae

American Journal of Gastroenterology

Volumn 110, Issue 12, 2015, Pages 1666-1674

  Almario, Christopher V ^a,b   May, Folasade P ^a,b,c   Shaheen, Nicholas J ^d   Murthy, Rekha ^a   Gupta, Kapil ^a   Jamil, Laith H ^a   Lo, Simon K ^a   Spiegel, Brennan M R ^a,c  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; ETHYLENE OXIDE; CARBAPENEM DERIVATIVE;

ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CARBAPENEM RESISTANT ENTEROBACTERIACEAE INFECTION; CHOLECYSTECTOMY; CHOLEDOCHOTOMY; COMMON BILE DUCT STONE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DECISION MAKING; DUODENOSCOPE; ENDOSCOPE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC SPHINCTEROTOMY; ENTEROBACTERIACEAE INFECTION; FOOD AND DRUG ADMINISTRATION; HEALTH CARE COST; HUMAN; INSTRUMENT STERILIZATION; MAJOR CLINICAL STUDY; PRETEST POSTTEST DESIGN; PRIORITY JOURNAL; PROBABILITY; QUALITY ADJUSTED LIFE YEAR; RISK MANAGEMENT; SENSITIVITY ANALYSIS; SYMPTOM; ADVERSE EFFECTS; ANTIBIOTIC RESISTANCE; COST BENEFIT ANALYSIS; DECISION SUPPORT SYSTEM; DIAGNOSTIC IMAGING; DISEASE TRANSMISSION; ECONOMICS; ENTEROBACTERIACEAE; ISOLATION AND PURIFICATION; LAPAROSCOPIC CHOLECYSTECTOMY; MICROBIOLOGY; MONTE CARLO METHOD; PREVENTION AND CONTROL; PRIMARY PREVENTION; PROCEDURES; TRANSMISSION; UNITED STATES;

CARBAPENEMS; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLECYSTECTOMY, LAPAROSCOPIC; CHOLEDOCHOLITHIASIS; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; DISEASE TRANSMISSION, INFECTIOUS; DRUG RESISTANCE, BACTERIAL; DUODENOSCOPES; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; MONTE CARLO METHOD; PRIMARY PREVENTION; QUALITY-ADJUSTED LIFE YEARS; STERILIZATION; UNITED STATES;

EID: 84951566765     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2015.358     Document Type: Article

References (40)

1. Andriulli A, Loperfi do S, Napolitano G, et al. Incidence rates of post-ERCP complications: A systematic survey of prospective studies. Am J Gastroenterol 2007; 102: 1781-8
2. Moff att DC, Yu BN, Yie W, et al. Trends in utilization of diagnostic and therapeutic ERCP and cholecystectomy over the past 25 years: A population-based study. Gastrointest Endosc 2014; 79: 615-22
3. Rutala WA, Weber DJ. Gastrointestinal endoscopes: A need to shift from disinfection to sterilization?. JAMA 2014; 312: 1405-6
4. Kovaleva J, Peters FT, Van der Mei HC, et al. Transmission of infection by fl exible gastrointestinal endoscopy and bronchoscopy. Clin Microbiol Rev 2013; 26: 231-54
5. Anderson DJ, Shimpi RA, McDonald JR, et al. Infectious complications following endoscopic retrograde cholangiopancreatography: An automated surveillance system for detecting postprocedure bacteremia. Am J Infect Control 2008; 36: 592-4
6. Epstein L, Hunter JC, Arwady MA, et al. New Delhi metallo-beta-lactamase-producing carbapenem-resistant Escherichia coli associated with exposure to duodenoscopes. JAMA 2014; 312: 1447-55
7. Alrabaa SF, Nguyen P, Sanderson R, et al. Early identifi cation and control of carbapenemase-producing Klebsiella pneumoniae, originating from contaminated endoscopic equipment. Am J Infect Control 2013; 41: 562-4
8. Gastmeier P, Vonberg RP. Klebsiella spp. in endoscopy-Associated infections: we may only be seeing the tip of the iceberg. Infection 2014; 42: 15-21
9. Alfa MJ. Monitoring and improving the effectiveness of cleaning medical and surgical devices. Am J Infect Control 2013; 41: S56-9
10. Aumeran C, Poincloux L, Souweine B, et al. Multidrug-resistant Klebsiella pneumoniae outbreak aft er endoscopic retrograde cholangiopancreatography. Endoscopy 2010; 42: 895-9
11. Doherty DE, Falko JM, Lefk ovitz N, et al. Pseudomonas aeruginosa sepsis following retrograde cholangiopancreatography (ERCP. Dig Dis Sci 1982; 27: 169-70
12. Muscarella LF. Investigation and prevention of infectious outbreaks during endoscopic retrograde cholangiopancreatography. Endoscopy 2010; 42: 957-9
13. Wendorf KA, Kay M, Baliga C, et al. Endoscopic retrograde cholangiopancreatography-Associated AmpC Escherichia coli outbreak. Infect Control Hosp Epidemiol 2015; 36: 634-42
14. Smith ZL, Oh YS, Saeian K, et al. Transmission of carbapenem-resistant Enterobacteriaceae during ERCP: time to revisit the current reprocessing guidelines. Gastrointest Endosc 2015; 81: 1041-5
15. Cedars-Sinai. Media Statement Regarding CRE and Duodenoscope 2015, [cited 4 March 2015]; Available from http://cedars-sinai.edu/About-Us/News/News-Releases-2015/Media-Statement-Regarding-CRE-And-Duodenoscope.aspx
16. UCLA Health System. UCLA notifies patients who received endoscopic procedures 2015, [cited 1 March 2015]; Available from http://newsroom. ucla.edu/releases/ucla-notifies-patients-who-received-endoscopicprocedures
17. U.S. Food and Drug Administration. Olympus Validates New Reprocessing Instructions for Model TJF-Q180V Duodenoscopes 2015, [cited 26 March 2015]; Available from http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm439999.htm?source=govdelivery&utm-medium=email&utm-source=govdelivery&zbrandid=439&zidType=CH&z id=9415155&zsubscriberId=328595175&zbdom=http://www.informz.net
18. Agency for Healthcare Research and Quality. HCUPnet 2015, [cited 26 March 2015]; Available from http://hcupnet.ahrq.gov/HCUPnet.jsp
19. Ducomble T, Faucheux S, Helbig U, et al. Large hospital outbreak of KPC- 2-producing Klebsiella pneumoniae: investigating mortality and the impact of screening for KPC-2 with polymerase chain reaction. J Hosp Infect 2015; 89: 179-85
20. Neuner EA, Yeh JY, Hall GS, et al. Treatment and outcomes in carbapenemresistant Klebsiella pneumoniae bloodstream infections. Diagn Microbiol Infect Dis 2011; 69: 357-62
21. Li VK, Yum JL, Yeung YP. Optimal timing of elective laparoscopic cholecystectomy aft er acute cholangitis and subsequent clearance of choledocholithiasis. Am J Surg 2010; 200: 483-8
22. U.S. Food and Drug Administration. Supplemental Measures to Enhance Duodenoscope Reprocessing: FDA Safety Communication 2015, [cited 10 August 2015]; Available from http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm454766.htm
23. Centers for Disease Control and Prevention. Interim duodenoscope surveillance protocol 2015, [cited 9 April 2015]; Available from http://www. cdc.gov/hai/organisms/cre/cre-duodenoscope-surveillance-protocol.html
24. Neumann PJ, Cohen JT, Weinstein MC. Updating cost-eff ectiveness--The curious resilience of the 50,000-per-QALY threshold. N Engl J Med 2014; 371: 796-7
25. Braithwaite RS, Meltzer DO, King JT Jr, et al. What does the value of modern medicine say about the 50,000 per quality-Adjusted life-year decision rule?. Med Care 2008; 46: 349-56
26. Hirth RA, Chernew ME, Miller E, et al. Willingness to pay for a quality-Adjusted life year: in search of a standard. Med Decis Making 2000; 20: 332-42
27. The Institute for Clinical Research and Health Policy Studies. Cost-Eff ectiveness Analysis Registry 2015, [cited 26 March 2015]; Available from https://research.tuft s-nemc.org/cear4/Home.aspx
28. American Medical Association. CPT Code/Relative Value Search 2015, [cited 23 March 2015]; Available from https://ocm.ama-Assn.org/OCM/CPTRelativeValueSearch.do.
29. Centers for Medicare & Medicaid Services. Physician Fee Schedule Search 2015, [cited 26 March 2015]; Available from http://www.cms.gov/apps/physician-fee-schedule/search/search-criteria.aspx
30. Bureau of Labor Statistics. CPI Infl ation Calculator 2015, [cited 6 April 2015]; Available from http://www.bls.gov/data/infl ation-calculator.htm
31. Helling TS, Khandelwal A. The challenges of resident training in complex hepatic, pancreatic, and biliary procedures. J Gastrointest Surg 2008; 12: 153-8
32. Novak D, Amin R. Lawsuit says woman died a year aft er contracting 'superbug'CRE at Lutheran General. Chicago Sun-Times, 24 May 2015
33. Aleccia J. Widow sues Virginia Mason; hospital begins notifying superbug,victims. The Seattle Times, 5 March 2015
34. Keus F, Gooszen HG, Van Laarhoven CJ. Open, small-incision, or laparoscopic cholecystectomy for patients with symptomatic cholecystolithiasis. An overview of Cochrane Hepato-Biliary Group reviews. Cochrane Database Syst Rev 2010, Cd008318
35. Alexakis N, Connor S. Meta-Analysis of one- vs. two-stage laparoscopic/endoscopic management of common bile duct stones. HPB (Oxford 2012; 14: 254-9
36. Dasari BV, Tan CJ, Gurusamy KS, et al. Surgical versus endoscopic treatment of bile duct stones. Cochrane Database Syst Rev 2013; 12: Cd003327
37. Fowler RA, Hill-Popper M, Stasinos J, et al. Cost-eff ectiveness of recombinant human activated protein C and the influence of severity of illness in the treatment of patients with severe sepsis. J Crit Care 2003; 18: 181-91
38. Howard K, Lord SJ, Speer A, et al. Value of magnetic resonance cholangiopancreatography in the diagnosis of biliary abnormalities in postcholecystectomy patients: A probabilistic cost-eff ectiveness analysis of diagnostic strategies. Int J Technol Assess Health Care 2006; 22: 109-18
39. Wilson E, Gurusamy K, Gluud C, et al. Cost-utility and value-of-information analysis of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Br J Surg 2010; 97: 210-9
40. Johner A, Raymakers A, Wiseman SM. Cost utility of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Surg Endosc 2013; 27: 256-62